Subscribe To
New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer
Real-World Data Show No Association Between Patient Characteristics and Risk of Myelosuppressive Events RESEARCH TRIANGLE PARK, N.C., May 16, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today described recently presented real-world data that confirm a consistent risk of myelosuppressive events (neutropenia, anemia, thrombocytopenia) across patients with small cell lung […] The post New Study Confirms Consistent Risk of Myelosuppression Acros...
Read More
Content Topics
Study
Confirms
Consistent
Risk
Myelosuppression
Across
Patients
Receiving
Chemotherapy
Cancer
Forex
Posted: May 16 2023, 11:30
Author Name: forextv
Views: 110432